Citizens raised the firm’s price target on Lantheus (LNTH) to $85 from $78 and keeps an Outperform rating on the shares. Sales and EPS handily exceeded consensus estimates in Q4, the analyst tells investors in a research note. Citizens remains encouraged about the development of some royalty opportunities, including Flyrcado and Pylclari, both of which could potentially start to contribute at a meaningful clip in the medium term.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on LNTH:
- Lantheus Earnings Call Maps Painful Reset Before 2027
- Lantheus downgraded to Hold from Buy at JonesResearch
- Lantheus price target raised to $85 from $75 at TD Cowen
- Lantheus: Resilient Pylarify Performance and Cash Generation Underpin Buy Rating Despite Near‑Term Pricing Headwinds
- Lantheus upgraded to Outperform from Market Perform at William Blair
